본 연설문은 Secretary Antony J. Blinken의 「합성마약 대응을 위한 글로벌 연대」 장관급 화상회의에서의 개회사를 편집한 것입니다.
길이: 599단어 (5분 11초)
Secretary Antony J. Blinken Opening Remarks at a Virtual Ministerial Meeting to Launch the Global Coalition to Address Synthetic Drugs
Glossary
Part 1 |
1 | Global Coalition to Address Synthetic Drug Threats | 합성 마약 위협에 대응하는 국제 연합 |
2 | National Drug Control Strategy | 국가마약통제전략 |
3 | methamphetamine | 메스암페타민 |
4 | tramadol | 트라마돌 |
5 | Captagon | 캡타곤 |
6 | Ketamine | 케타민 |
7 | fentanyl | 펜타닐 |
8 | precursor chemical | 전구물질/마약류 원료물질 (마약을 제조하는 데에 사용되는 원료물질로서 마약으로 제조되기 바로 직전 단계의 물질) |
9 | naloxone | 낼럭손 |
Thank you very much. Colleagues, on behalf of President Biden, welcome. Welcome to the launch of the Global Coalition to Address Synthetic Drug Threats. We are grateful to the senior government officials from more than 80 countries, as well as leaders from over a dozen regional and international organizations for joining us (inaudible).
We feel this acutely in the United States. Synthetic drugs are the number one killer of Americans aged 18 to 49. And it’s almost worth pausing on that fact. The number one killer of Americans aged 18 to 49 – synthetic drugs, notably fentanyl. Nearly 110,000 Americans died last year of a drug overdose. Two-thirds of those deaths involved synthetic opioids. For the individuals, the families, the communities affected, the pain caused by these deaths and by the millions who suffer with substance use is immeasurable. It’s also inflicting a massive economic toll – nearly $1.5 trillion in the United States in 2020 alone, according to a report by our Congress; our public health system, our criminal justice system all bearing the costs.
That’s why President Biden has made it a top priority for us to tackle two of the critical drivers of this epidemic in the United States: untreated addiction, and drug trafficking. In 2022 our administration released a National Drug Control Strategy that for the first time the United States embraces harm reduction efforts that meet people where they are and engages them in care and services. America is far from alone in facing this challenge. According to the United Nations, more than 34 million people around the world use methamphetamines or other synthetic stimulants annually. And every region is experiencing an alarming rise in other synthetic drugs. In Africa, it’s tramadol; in the Middle East, fake Captagon pills; in Asia, Ketamine.
One of the main reasons we wanted to come together today is because we believe the United States is a canary in the coal mine when it comes to fentanyl, an exceptionally addictive and deadly synthetic drug. Having saturated the United States market, transnational criminal enterprises are turning elsewhere to expand their profits. If we don’t act together with fierce urgency, more communities around the world will bear the catastrophic costs that are already affecting so many American cities, so many American towns.
The criminal organizations that traffic synthetic drugs are extremely adept at exploiting weak links in our interconnected global system. When one government aggressively restricts the precursor chemical, traffickers simply buy it elsewhere. When one country closes off a transit route, traffickers quickly shift to another. This is the definition of a problem that no country can solve alone. That’s why we’re creating this global coalition.
We’re focused on three key areas: first, preventing the illicit manufacture and trafficking of synthetic drugs; second, detecting emerging threats and patterns of use; and third, advancing public health interventions and services to prevent and reduce drug use, to save lives, to support recovery for people who use drugs.
Now, of course, we’re not starting from scratch. For years, governments, regional and international organizations, health workers, and communities have been coming up with innovative solutions on each of these priorities. Countries in the Western Hemisphere are working with the Organization of American States to develop and implement early warning systems to detect emerging synthetic drug use.
Take-home naloxone kits, pioneered by countries in Europe, have been adopted by countries in Central Asia and other regions. This coalition – this coalition is intended to build on this and other important efforts, not take their place, including efforts in the United States, which are among those shared lessons learned.